275
Participants
Start Date
October 5, 2005
Primary Completion Date
April 30, 2018
Study Completion Date
April 30, 2018
OK432
OK432 will be injected at dosage of 0.01 to 0.05 mg/mL 6-12 weeks apart up to 4 injections total.
SUNY Health Science Center, Syracuse
Children's National Medical Center, Washington D.C.
Children's Hospital of the Kings Daughter, Norfolk
All Children's Hospital, St. Petersburg
Vanderbilt University Hospital, Nashville
Spectrum Health-SHMG Ear, Nose, & Throat, Grand Rapids
Richard Smith, MD, Iowa City
Children's Hospital of Wisconsin, Milwaukee
University of Wisconsin Hospital & Clinic, Madison
Children's Hospitals & Clinics of Minnesota - Minneapolis, Minneapolis
Children's ENT of Houston, Houston
The Children's Hospital of Denver, Denver
Rady Children's Hospital & Health Center San Diego, San Diego
Oregon Health Sciences University, Portland
Richard JH Smith
OTHER